Dalfampridine 82249-0702-60
- Manufacturer
- Civicascript Llc
- Dosage Form
- Tablet, Film Coated, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- July 21, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA206765
Need to source Dalfampridine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dalfampridine | 10 mg/1 |
Drug Class
Potassium Channel Blocker [EPC]Potassium Channel Antagonists [MoA]Potassium Channel Blocker [EPC]
Selected Package
82249-0702-60Selected60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (82249-702-60)